Angiotensin II Receptor Antagonists in Chronic Heart Failure

This publication has 57 references indexed in Scilit:

• Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (the OPTIMAAL trial)
  The American Journal of Cardiology, 2001
• Bradykinin B ₂ Receptor Antagonism Attenuates Blood Pressure Response to Acute Angiotensin-Converting Enzyme Inhibition in Normal Men
  Hypertension, 2000
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Effects of losartan and captopril on QT dispersion in elderly patients with heart failure
  The Lancet, 1999
• Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design
  The American Journal of Cardiology, 1999
• Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
  International Journal of Cardiology, 1997
• Comparison of Angiotensin-Converting Enzyme Inhibition with Angiotensin II Receptor Antagonism in the Human Forearm
  Journal of Cardiovascular Pharmacology, 1993
• Regional hemodynamic effects of perindopril in congestive heart failure
  American Heart Journal, 1993
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987
• Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
  Circulation, 1981